The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes

被引:0
|
作者
M. Trojano
D. Paolicelli
机构
[1] Department of Neurological and Psychiatric Sciences,
[2] University of Bari,undefined
[3] Piazza Giulio Cesare 11,undefined
[4] I-70124 Bari,undefined
[5] Italy,undefined
来源
Neurological Sciences | 2001年 / 22卷
关键词
Key words Multiple sclerosis; Differential diagnosis; Relapsing/progressive neurological syndromes;
D O I
暂无
中图分类号
学科分类号
摘要
In the absence of pathognomonic clinical features or a definitive laboratory test, multiple sclerosis (MS) remains ultimately a diagnosis of exclusion. Accurate diagnosis is increasingly important with available disease modifying therapy. Unfortunately the rate of misdiagnosis remains around 5%–10%, indicating that 1 in 20 patients thought to have MS has, instead, a condition resembling MS. In this review we describe conditions that may be confused with MS because they can present as lesions disseminated in time, space, or both. Conditions often confused with MS may be inflammatory (systemic lupus erythematosus, Sjögren's syndrome, vasculitis, sarcoidosis, Behçet's disease), infectious (Lyme disease, syphilis, progressive multifocal leukoencephalopathy, HTLV-1 infection, herpes zoster), genetic (lysosomal disorders, adrenoleukodystrophy, mitochondrial disorders, CADASIL), metabolic (vitamin B12 deficiency), neoplastic (CNS lymphoma) and spinal (degenerative and vascular malformations) diseases. The key to the accurate diagnosis of MS is vigilance for atypical features, suggesting the possibility of an alternative diagnosis.
引用
收藏
页码:S98 / S102
相关论文
共 50 条
  • [21] Cranial nerve, brainstem and cerebellar syndromes in the differential diagnosis of multiple sclerosis
    M. Zaffaroni
    S. M. Baldini
    A. Ghezzi
    Neurological Sciences, 2001, 22 : S74 - S78
  • [22] Chronic Relapsing Inflammatory Optic Neuropathy: A Differential Diagnosis from Multiple Sclerosis
    Di Guglielmo, Federico
    Kremenchutzky, Marcelo
    NEUROLOGY, 2012, 78
  • [23] Clinical parameters at multiple sclerosis diagnosis and cognitive performance in relapsing-remitting multiple sclerosis patients
    Anabel Silva, Berenice
    Laura Saladino, Maria
    Eizaguirre, Barbara
    Alonso, Ricardo
    Cecilia Pita, Maria
    Merino, Angeles
    Yastremiz, Cecilia
    Cabral, Nadia
    Mariangeli, Aldana
    Vanotti, Sandra
    Garcea, Orlando
    Caceres, Fernando
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (01) : 151 - 152
  • [24] Difficulties in diagnosis of primary progressive multiple sclerosis: a clinical perspective
    Blok, K.
    Wokke, B.
    Smolders, J.
    de Beukelaar, J.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 145 - 146
  • [25] Review of the diagnosis and clinical features of multiple sclerosis in China
    Cheng, Xiao-Juan
    Xu, Li-Zhen
    NEUROSCIENCE BULLETIN, 2009, 25 (01) : 38 - 42
  • [26] Neurological syndromes and the traveller: An approach to differential diagnosis
    Day, JN
    Lalloo, DG
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 : I2 - I9
  • [27] Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis REPLY
    Hauser, Stephen L.
    Belachew, Shibeshih
    Kappos, Ludwig
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (17): : 1694 - 1694
  • [28] Adipokine Levels in Relapsing and Progressive Forms of Multiple Sclerosis
    Messina, Silvia
    Vargas-Lowy, David
    Gandhi, Roopali
    Kivisakk, Pia
    Healy, Brian
    Patti, Francesco
    Zappia, Mario
    Khoury, Samia
    Weiner, Howard
    Chitnis, Tanuja
    NEUROLOGY, 2012, 78
  • [29] Predicting disability worsening in relapsing and progressive multiple sclerosis
    Simmons, Sarah B.
    Schippling, Sven
    Giovannoni, Gavin
    Ontaneda, Daniel
    CURRENT OPINION IN NEUROLOGY, 2021, 34 (03) : 312 - 321
  • [30] Cognitive Performance and Clinical Profiles of Relapsing and Progressive Multiple Sclerosis Patients in Hong Kong
    Ng, Angel
    Wong, Adrian
    Au, Cheryl
    Mok, Vincent
    Lau, Alexander
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP51 - NP51